Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.19 +0.92 (+12.65%)
As of: Nov 11, 2026 · 3:52 PM EST

Olema Pharmaceuticals (OLMA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Olema Pharmaceuticals (OLMA) posted Return on Capital Employed [ROCE] of -48.54% for Q2 2026, down 5.21 percentage points from -43.33% a year earlier and down 6.91 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Olema Pharmaceuticals' Return on Capital Employed [ROCE] came in at -40.58%, up 3.58 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -17.54 percentage points (FY2021 to FY2025).
  • In prior years, Olema Pharmaceuticals' Return on Capital Employed [ROCE] was -44.15% in FY2024 (+2.57 pp), -46.72% in FY2023 (-2.00 pp), -44.72% in FY2022 (-21.68 pp) and -23.04% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -64.21% in Q3 2024 to a high of -19.49% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -0.39 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 15.90 percentage points; the weakest was Q1 2023, with a drop of 32.16 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -41.62% (Q1 2026), -45.69% (Q4 2025) and -50.80% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn - -64.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -64.06%
Jun 30, 2026 -48.54%
Mar 31, 2026 -41.62%
Dec 31, 2025 -45.69%
Sep 30, 2025 -50.80%
Jun 30, 2025 -43.33%
Mar 31, 2025 -35.32%
Dec 31, 2024 -47.61%
Sep 30, 2024 -64.21%
Jun 30, 2024 -52.29%
Mar 31, 2024 -44.94%
Dec 31, 2023 -39.87%
Sep 30, 2023 -46.42%
Jun 30, 2023 -59.14%
Mar 31, 2023 -60.84%
Dec 31, 2022 -51.62%
Sep 30, 2022 -44.38%
Jun 30, 2022 -38.17%
Mar 31, 2022 -28.68%
Dec 31, 2021 -24.33%
API Access

Olema Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY